The transfusion needs of an autologous bone marrow transplant patient with IgA deficiency

Transfusion

Volumn 39, Issue 5, 1999, Pages 457-459

  Meena Leist, Claire E ^a,b   Fleming, D R ^a   Heye, M ^a   Herzig, R H ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FRESH FROZEN PLASMA;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD COMPONENT THERAPY; BREAST CANCER; CASE REPORT; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOTHERAPY; THROMBOCYTOPHERESIS; TREATMENT PLANNING;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; IGA DEFICIENCY; TRANSPLANTATION, AUTOLOGOUS;

EID: 0032954338     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39050457.x     Document Type: Article

References (3)

1. Vengelen-Tyler V, ed. Technical manual. 12th ed. Bethesda: American Association of Blood Banks, 1996:549-550.
2. Sandler SG, Eckrich R, Malamut D, et al. Hemagglutination assays for the diagnosis and prevention of IgA anaphylactic transfusion reactions. Blood 1994;84:2031-5.
3. Vamvakas EC, Pineda AA. Allergic and anaphylactic reactions. In: Popovsky MA, ed. Transfusion reactions. Bethesda: AABB Press, 1996:81-124.